Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05623319 |
Title | Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC) (THOR) |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ITA |